Primary percutaneous interventions into the coronary arteries in patients with diabetes mellitus


Cite item

Full Text

Abstract

Aim. To investigate the specific features and results of percutaneous interventions (PCI) into the coronary arteries in patients with acute ST-segment elevation myocardial infarction (MI) and diabetes mellitus (DM) in clinical practice. Subjects and methods. A study group consisted of 120 patients with a history of type 2 DM, who had undergone primary PCI in 2008 to 2013. A comparison group included 601 patients without a history of DM. Results. Assessment of the results of hospital interventions revealed no differences between the study and comparison groups in mortality rates (4.1 and 3.2%, respectively; p=0.376), stent thromboses (0.8 and 1.2%, respectively; p=0.601), and recurrent MI (0 and 1.5%, respectively; p=0.189). No differences were determined in the combined index including death, recurrent MI, and stent thrombosis (5 and 5%; p=0.985). At the same time, the no-reflow phenomenon developed statistically significantly more frequently in the patients with DM (7.4 and 2.8%; p=0.019). Binary logistic regression established independent associations between the presence of DM and patient age (odds ratio (OR) 1.04; 95% confidence interval (CI) 1.02 to 1.07; p<0.001), female sex (OR 0.36; 95% CI 0.23 to 0.56; p<0.001), and higher body mass index (OR 1.1; 95% CI 1.06 to 1.16; p<0.04). Conclusion. Primary PCIs in patients with DM are an effective and safe method for revascularization in acute ST-segment elevation MI and these are not followed by increases in mortality and frequency of major poor cardiac complications at the hospital stage despite the more common development of the no-reflow phenomenon.

References

  1. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomized trials. Lancet. 2003; 61:13-20. doi: 10.1016/s0140-6736(03)12113-7
  2. Кузнецов В.А., Ярославская В.И., Пушкарев Г.С., Зырянов И.П., Бессонов И.С., Горбатенко Е.А., Нямцу А.М. Взаимосвязь чрескожных коронарных вмешательств при острых формах ишемической болезни сердца и показателей смертности населения Тюменской области. Российский кардиологический журнал. 2014;6(110):42-46. doi: 10.15829/1560-4071-2014-6-42-46
  3. De Luca G, Dirksen M, Spaulding C, Kelbaek H, Schalij M, Thuesen L, Van der Hoeven B, Vink M, Kaiser C, Musto C, Chechi T, Spaziani G, Diaz de la Llera L, Pasceri V, Di Lorenzo E, Violini R, Suryapranata H, Stone G. Impact of diabetes on long-term outcome after primary angioplasty insights from the DESERT cooperation. Diabetes Care. 2013;36:1020-1025. doi: 10.2337/dc12-1507
  4. Ergelen M, Uyarel H, Cicek G, Isik T, Osmonov D, Gunaydin Z, Bozbay M, Turer A, Gul M, Abanonu G. Which is worst in patients undergoing primary angioplasty for acute myocardial infarction? Hyperglycaemia? Diabetes mellitus? Or both? J Am Coll Cardiol. 2010;55(10):A104.E975. doi: 10.1016/s0735-1097(10)60976-x
  5. Барбараш Л.С., Ганюков В.И. Организация и тактика проведения чрескожного коронарного вмешательства при инфаркте миокарда с подъемом сегмента ST. Кемерово: Ареал; 2012.
  6. Дедов И.И., Шестакова М.В. Клинические рекомендации «Алгоритмы специализированной медицинской помощи больным сахарным диабетом». Сахарный диабет. 2015;18(1S): 1-112. doi: 10.14341/DM20151S1-112
  7. Kahn MB, Cubbon RM, Mercer B, Wheatcroft A C, Gherardi G, Aziz A, Baliga V, Blaxill JM, McLenachan JM, Blackman DJ, Greenwood JP, Wheatcroft S B. Association of diabetes with increased all-cause mortality following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction in the contemporary era. Diabet Vasc Dis Res. 2011;9(1):3-9. doi: 10.1177/1479164111427752
  8. Brener S, Mehran R, Dressler O, Cristea E, Stone GW. Diabetes Mellitus, Myocardial Reperfusion, and Outcome in Patients With Acute ST-Elevation Myocardial Infarction Treated With Primary Angioplasty (from HORIZONS AMI). Am J Cardiol. 2012;109(8): 1111-1116. doi: 10.1016/j.amjcard.2011.11.046
  9. Tisminetzky M, Joffe S, McManus DD, Darling C, Gore JM, Yarzebski J, et al. Decade-long trends in the characteristics, management and hospital outcomes of diabetic patients with ST-segment elevation myocardial infarction. Diabet Vasc Dis Res. 2014; 11(3):182-189. doi: 10.1177/1479164114524235
  10. Gore MO, Patel MJ, Kosiborod M, Parsons LS, Khera A, de Lemos JA, et al. Diabetes Mellitus and Trends in Hospital Survival After Myocardial Infarction, 1994 to 2006: Data From the National Registry of Myocardial Infarction. Circulation: Cardiovascular Quality and Outcomes. 2012;5(6):791-797. doi: 10.1161/circoutcomes.112.965491
  11. Ishihara M, Kagawa E, Inoue I, Kawagoe T, Shimatani Y, Kurisu S, Nakama Y, Maruhashi T, Ookawa K, Dai K, Aokage Y. Impact of Admission Hyperglycemia and Diabetes Mellitus on Short- and Long-Term Mortality After Acute Myocardial Infarction in the Coronary Intervention Era. AmJ Cardiol. 2007;99(12):1674-1679. doi: 10.1016/j.amjcard.2007.01.044
  12. Gruppetta M, Calleja N, Fava S. Long-Term Survival After Acute Myocardial Infarction and Relation to Type 2 Diabetes and Other Risk Factors. Clin Cardiol. 2010;33(7):424-429. doi: 10.1002/clc.20776
  13. Медикаментозное сопровождение чрескожного коронарного вмешательства. Под ред. Ганюкова В.И., Протопопова А.В. Новосибирск: Издательство «АРЕАЛ»; 2014.
  14. Collet JP, Montalescot G. The acute reperfusion management of STEMI in patients with impaired glucose tolerance and type 2 diabetes. Diab Vasc Dis Res. 2005;2(3):136. doi: 10.3132/dvdr.2005.021
  15. Ndrepepa G, Tiroch K, Fusaro M, Keta D, Seyfarth M, Byrne RA, Pache J, Alger P, Mehilli J, Schömig A, Kastrati A. 5-Year Prognostic Value of No-Reflow Phenomenon After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction. J Am Coll Cardiol. 2010:55(21):2383-2389. doi: 10.1016/j.jacc.2009.12.054

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2016 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies